Parakeet Health raises a $10M Series A led by Canvas Ventures to expand AI patient outreach beyond dermatology.
The Centers for Medicare and Medicaid Services finalized a demonstration program aimed at lowering the prices of ...
Bristol Myers discloses a fatal liver injury in its Phase 3 program for pulmonary fibrosis drug admilparant ahead of a Q4 ...
Sanofi pays Regeneron $1B upfront, with up to $7B more, to co-develop four long-acting immunology antibodies as Dupixent's patent cliff nears.
Merck's tulisokibart showed mid-stage success in hidradenitis suppurativa, with 72% high-dose patients seeing 50%+ abscess ...
Forget Wegovy and Zepbound. Never mind CagriSema, and even retatrutide. The latest big name in obesity is eloraTZP. Data ...
The American Biotech Innovation Alliance pressed Congress this week on US-China biotech competition, citing FDA capacity ...
The cash should give the Stockholm-based biotech a runway “well into 2029,” CEO Patrik Strömberg told Endpoints News in ...
Varda Space Industries raises a $251M Series D, valuing it at $1.6B, to advance space-based drug manufacturing using low ...
Ex-Genentech AI leaders including NYU's Kyunghyun Cho launch health startup Ortet with a $500M commitment from Matt Holt's ...
ARCH and Population Health launch Somnivera with a $10.5M-upfront deal for an ex-China sleep drug from Jiangsu Nhwa.
Massachusetts is often considered the epicenter of the biotech industry because of its nucleus of world-class research institutions churning out new scientists and new startups.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results